Medium materiality5/10
Jefferies raises Replimune price target to $29 from $24
Why it may matterVerify against the original reporting
Bullish analyst view, though the target is a forecast rather than a guarantee.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Jefferies lifted its REPL target by about 21% to $29, versus a posted price of $16.06, indicating substantial analyst-forecast upside.
- Target raised from $24 to $29.
- Posted price: $16.06.
Key facts
- 01
Target: $29
- 02
Posted price: $16.06
- 03
Analyst firm: Jefferies
- 04
Analyst: Roger Song
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.